Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $8.33 billion. The enterprise value is $7.49 billion.
| Market Cap | 8.33B |
| Enterprise Value | 7.49B |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 64.71 million shares outstanding. The number of shares has increased by 4.05% in one year.
| Current Share Class | 64.71M |
| Shares Outstanding | 64.71M |
| Shares Change (YoY) | +4.05% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 102.76% |
| Float | 52.89M |
Valuation Ratios
The trailing PE ratio is 105.43 and the forward PE ratio is 67.65.
| PE Ratio | 105.43 |
| Forward PE | 67.65 |
| PS Ratio | 29.54 |
| Forward PS | 21.45 |
| PB Ratio | 9.89 |
| P/TBV Ratio | 9.90 |
| P/FCF Ratio | 63.80 |
| P/OCF Ratio | 63.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 125.09, with an EV/FCF ratio of 57.37.
| EV / Earnings | 90.35 |
| EV / Sales | 26.56 |
| EV / EBITDA | 125.09 |
| EV / EBIT | 128.40 |
| EV / FCF | 57.37 |
Financial Position
The company has a current ratio of 21.71, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.71 |
| Quick Ratio | 21.58 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.07 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.98% and return on invested capital (ROIC) is 61.79%.
| Return on Equity (ROE) | 10.98% |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 61.79% |
| Return on Capital Employed (ROCE) | 6.88% |
| Weighted Average Cost of Capital (WACC) | 12.62% |
| Revenue Per Employee | $2.00M |
| Profits Per Employee | $588,007 |
| Employee Count | 141 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $1.43 million in taxes.
| Income Tax | 1.43M |
| Effective Tax Rate | 1.69% |
Stock Price Statistics
The stock price has increased by +65.74% in the last 52 weeks. The beta is 1.52, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +65.74% |
| 50-Day Moving Average | 145.39 |
| 200-Day Moving Average | 113.77 |
| Relative Strength Index (RSI) | 31.49 |
| Average Volume (20 Days) | 830,587 |
Short Selling Information
The latest short interest is 9.35 million, so 14.44% of the outstanding shares have been sold short.
| Short Interest | 9.35M |
| Short Previous Month | 8.14M |
| Short % of Shares Out | 14.44% |
| Short % of Float | 17.67% |
| Short Ratio (days to cover) | 13.63 |
Income Statement
In the last 12 months, PTGX had revenue of $281.99 million and earned $82.91 million in profits. Earnings per share was $1.22.
| Revenue | 281.99M |
| Gross Profit | 281.99M |
| Operating Income | 58.34M |
| Pretax Income | 84.34M |
| Net Income | 82.91M |
| EBITDA | 59.88M |
| EBIT | 58.34M |
| Earnings Per Share (EPS) | $1.22 |
Balance Sheet
The company has $782.58 million in cash and $9.22 million in debt, with a net cash position of $840.24 million or $12.98 per share.
| Cash & Cash Equivalents | 782.58M |
| Total Debt | 9.22M |
| Net Cash | 840.24M |
| Net Cash Per Share | $12.98 |
| Equity (Book Value) | 841.54M |
| Book Value Per Share | 13.01 |
| Working Capital | 769.97M |
Cash Flow
In the last 12 months, operating cash flow was $131.20 million and capital expenditures -$615,000, giving a free cash flow of $130.58 million.
| Operating Cash Flow | 131.20M |
| Capital Expenditures | -615,000 |
| Depreciation & Amortization | 1.54M |
| Net Borrowing | n/a |
| Free Cash Flow | 130.58M |
| FCF Per Share | $2.02 |
Margins
Gross margin is 100.00%, with operating and profit margins of 20.69% and 29.40%.
| Gross Margin | 100.00% |
| Operating Margin | 20.69% |
| Pretax Margin | 29.91% |
| Profit Margin | 29.40% |
| EBITDA Margin | 21.24% |
| EBIT Margin | 20.69% |
| FCF Margin | 46.31% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.05% |
| Shareholder Yield | -4.05% |
| Earnings Yield | 1.00% |
| FCF Yield | 1.57% |
Analyst Forecast
The average price target for PTGX is $178.21, which is 38.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $178.21 |
| Price Target Difference | 38.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 99.96% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 72.22 and a Piotroski F-Score of 6.
| Altman Z-Score | 72.22 |
| Piotroski F-Score | 6 |